"10.1371_journal.pmed.0050083","plos medicine","2008-04-15T00:00:00Z","Michael J Sorich; Nicolas Pottier; Deqing Pei; Wenjian Yang; Leo Kager; Gabriele Stocco; Cheng Cheng; John C Panetta; Ching-Hon Pui; Mary V Relling; Meyling H Cheok; William E Evans","Hematological Malignancies Program and the Department of Pharmaceutical Sciences, St. Jude Childrens Research Hospital, Memphis, Tennessee, United States of America; Sansom Institute, University of South Australia, Adelaide, Australia; EA2679, Faculté de Médecine de Lille, Pole Recherche, Lille, France; Department of Biostatistics, St. Jude Childrens Research Hospital, Memphis, Tennessee, United States of America; Department of Hematology-Oncology, St. Anna Childrens Hospital, Vienna, Austria; Instituto di Ricovero e Cura a Carattere Scientifico, Burlo Garofolo and University of Trieste, Trieste, Italy; University of Tennessee, Memphis, Tennessee, United States of America; Department of Oncology, St. Jude Childrens Research Hospital, Memphis, Tennessee, United States of America; Pharmacogenetics of Anticancer Agents Research Group, National Institutes of Health Pharmacogenetics Research Network, Memphis, Tennessee, United States of America, and Chicago, Illinois, United States of America","MJS, C-HP, MHC, and WEE designed the experiments and the study. MJS, DP, WY, GS, CC, JCP, MVR, WEE, and MHC analyzed the data. C-HP enrolled and treated patients. NP wrote the first draft of the paper. MJS, WY, LK, GS, CC, C-HP, MVR, MHC, and WEE contributed to writing the paper. MHC collected gene expression and patient data for this study.","The authors have declared that no competing interests exist.","2008","04","Michael J Sorich","MJS",12,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA
